PRECLINICAL COMBINATION OF A NOVEL IRE1 RNASE INHIBITOR MKC-8866 AND TYROSINE KINASE INHIBITION ACTS SYNERGISTIC IN ACUTE LYMPHOBLASTIC LEUKEMIA
Abstract
no abstract
Laurent Jonchère : Connect in order to contact the contributor
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01585927
Submitted on : Tuesday, September 12, 2017-11:02:33 AM
Last modification on : Wednesday, March 30, 2022-2:38:11 PM